We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Yuflyma
Device/Product Name
Yuflyma
Active ingredients
Adalimumab
AusPAR Date
Published
Submission Number
PM-2021-01170-1-3
Submission Type
New biosimilar medicine
Decision
Approved